Extended Bead Information
The beads evaluated for cell isolation differ in bead composition and surface coating. While not all bead composition information is available from the manufacturer, the available information for users on each bead type is compiled in Table S1 . Dynabeads M-270 Epoxy (14311D, ThermoFisher) are 2.8 µm superparamagnetic beads coated with glycidyl ether (epoxy) functional groups to faciliate antibody binding (binds to primary amino acids and sulfydral groups). The binding capacity of the beads is reported as 5 -10 µg of IgG per milligram of M-270s. M-270s are described by the manufacturer as nonporous, hydrophillic beads with low non-specific binding. Beads are supplied lyophilized. Dynabeads M-280 Streptavidin (11205D, ThermoFisher) are also 2.8 µm superparamagnetic beads, but are hydrophobic. Due to their streptavidin coating, M-280s enable capture of biotin molecules (inlcuding biotinylated antibodies). The M-280s are coated with a monolayer of recombinant streptavidin covalently bound to the bead's surface, and are subsequently blocked with BSA. Beads are supplied in PBS (pH 7.4) with 0.1% BSA and 0.02% sodium azide. As per manufacturer specifications, the binding capacity of one milligram of M-280s is ~10 µg of biotinylated IgG. Sera-Mag SpeedBeads Streptavidin-Blocked Magnetic Particles (21152104011150, GE Healthcare Life Sciences) are 1 µm diameter streptavidin-coated beads. The beads consist of a polystyrene core encapsulated in two layers of magnetite coavalently bound to streptavidin. In addition, a proprietary blocking reagent is then used to reduce nonspecific binding to the surface of the bead (non-surfactant, and non-protein reagent). Particles are supplied in water containing 0.05% sodium azide.
The final two bead types are both releasable, enabling isolation of a bead-free cell population. Dynabeads FlowComp beads (11061D, ThermoFisher) are 2.8 µm superparamagnetic polymer (unspecified) coated beads, with recominant streptavidin. The beads are supplied as part of a kit, which enables the user to label their own protein or antibody with a modified biotin, DSB-X biotin (derivative of desthiobiotin), for conjugation to the FlowComp Flexi beads (coated in a modified streptavidin as described by the manufacterer). By utilizing the DSB-X biotin-labeled antibody, the bead-antibody complex can be dissociated in release buffer, or by introducing D-biotin (B-1595 or B-20656, ThermoFisher) or D-desthiobiotin (D-20657, ThermoFisher) at a neutral pH. Beads are supplied in PBS (pH 7.4) supplemented with 0.1% BSA and 0.02% sodium azide. CELLection Biotin Binder beads (11533D, ThermoFisher) are 4.5 µm diameter superparamagnetic polystyrene beads coated with DNA linker containing a streptavidin on the end. Biotinylated antibodies are then bound to the DNA linker, which can then be cleaved (DNase I) after isolation. Beads are supplied in PBS (pH 7.4) supplemented with 0.1% Tween and 0.02% sodium azide. Table S1 . Overview of the cell isolation magnetic beads compared. Table S2 . Calculated fifty percent maximal anti-EpCAM antibody binding concentration values across M-280, FlowComp, CELLection, and Sera-Mag magnetic beads. For all experiments (unless noted), each bead type was conjugated to antibody at the identified density. M-270s were not analyzed in this way due to the provided manufacturer's batch conjugation protocol. Figure S1 . Panel of prostate cancer cell lines screened for relative EpCAM expression using a fluorescent anti-EpCAM antibody. Data normalized to average maximal EpCAM expression (LNCaP). Based on the data, a low, medium, and high EpCAM expresser were chosen for characterization with (Du145, 22Rv1, and LNCaPs respectively. Figure S2 . Quantity of cell isolation magnetic beads used per isolation titrated against two cell lines. Due to consistency in capture across bead types, 100 µg of magnetic beads was chosen for each bead type to move forward with in evaluated samples. Figure S3 . Overall capture (i.e., both released and bound captured cells compared to total population) across different release conditions. Capture remained consistent across conditions while the released population changed. Figure S4 . Representative multi-channel (bright field, 390, 485, 560, 648 and 740 nm) images of each magnetic bead type imaged under identical acquisition settings on glass. For visual comparison, fluorescence images within the same channel are displayed with the same contrast, and the lower limit is set at 3 standard deviations below the mean of the background intensity.
